Edit |   |
---|---|
Antigenic Specificity | CD51+CD61 |
Clone | monoclonal |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | IP, IF, FuncS, FC, Neut, ELISA, ICC, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD51+CD61 Recombinant Antibody (Etaracizumab). Recombinant monoclonal antibody to Human CD51+CD61. Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. |
Immunogen | The details of the immunogen for this antibody are not available. |
Other Names | Etaracizumab;abegrin;892553-42-3;MEDI-522;hLM609;Vitaxin;LM609;etaratuzumab;MEDI-522;Abegrin;ITGAV;integrin, alpha V;antigen identified by monoclonal L230, integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51), MSK8, vitronectin recept |
Gene, Accession # | n/a |
Catalog # | TAB-025 |
Price | please inquire |
Order / More Info | CD51+CD61 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |